With Medicare Support, CGX / PGX Genetic Cancer Testing Goes Mainstream. Medicare will now cover FDA-approved CGX / PGX gene sequencing tests to match patients with cancer treatments. This year, nearly 1.7 million Americans will be diagnosed with cancer. Most...




